Episode 23 - Greg Kunst and Corneal Endothelial Therapy for Partial or Full Vision Loss

The Future of Pharma by Samir Gondalia, ISPE Boston

My guest in this episode is Greg Kunst, CEO of Aurion Biotech. At Aurion, Greg and his colleagues are working on a regenerative treatment (corneal endothelial cell therapy) for millions of people who have partial or comp...View more